The literature evidencing the role of iron in promoting a range of neoplasms in humans and animals prompted us to search for a possible association between chemically induced hemosiderosis and hemangiosarcomas in the liver of mice in selected studies conducted by the National Toxicology Program (NTP). Its historical control database was examined for studies in which treatment-related liver hemangiosarcoma was noted; 130 consecutive NTP studies in B6C3F1 mice from Technical Report (TR)-340 to TR-493 were evaluated. Three compounds (2-butoxyethanol, p-nitroaniline, and para-chloroaniline) were associated with a relatively high incidence of Kupffer cell pigmentation consisting of hemosiderin in both sexes; only the male mice developed a relatively low incidence of treatment-related hemangiosarcoma. With a fourth compound (o-nitroanisole), a relatively low incidence (16/50, high-dose males) of chemical-related hemosiderosis was noted, with no associated increase of hemangiosarcoma. Two chemicals (pentachlorophenol and tetrafluoroethylene) increased the incidence of liver hemangiosarcoma in male and female mice, with no increase in Kupffer cell pigmentation. The overall association between liver hemangiosarcoma and Kupffer cell pigmentation was highly significant (p < 0.001). The cause for hemosiderosis in all cases was the erythrocytic hemolytic effect of the compounds. The reason for the sex-increased susceptibility for development of hemangiosarcoma is unknown but may be due to a hormone-related, reduced antioxidative defensive capacity through modulation of the activities of antioxidative enzymes.

Download full-text PDF

Source
http://dx.doi.org/10.1080/019262330403200201DOI Listing

Publication Analysis

Top Keywords

liver hemangiosarcoma
16
kupffer cell
12
cell pigmentation
12
association liver
8
national toxicology
8
toxicology program
8
low incidence
8
hemangiosarcoma
7
hemangiosarcoma secondary
4
secondary iron
4

Similar Publications

Background: Hepatic sarcomatoid carcinoma (HSC) and hepatic sarcoma (HS) are rare malignancies. Without pathology, the differential diagnosis between these two tumors is difficult due to their frequent overlaps in clinical presentations and imaging features. Currently, there are limited analyses about the ultrasound (US), contrast-enhanced ultrasound (CEUS) and contrast-enhanced computer tomography (CECT) characteristics of HSC and HS.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatic angiosarcoma (HA) is a rare cancer with no standardized treatment protocols; a study aims to analyze clinicopathologic data, prognostic factors, and treatment outcomes.
  • From 2000 to 2021, data from 389 HA patients showed a low overall 3-year survival rate of only 6.7%, with surgical resection offering the best outcome at a 1-year survival rate of 18.20%.
  • Key negative prognostic factors included age over 70, male sex, and distant tumor stage, while female sex appeared to be a positive factor, suggesting a need for improved management strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Hemangiomas are benign vascular tumors that primarily affect the skin and soft tissues, with anastomosing hemangioma (AH) being a specific subtype that mimics more serious conditions like angiosarcoma; there are fewer than 300 reported cases of renal hemangiomas.
  • A case study of a 28-year-old male revealed a left renal mass identified during tests for abdominal pain, with subsequent imaging and surgery confirming the diagnosis of AH through histopathological analysis and specific immunohistochemical markers.
  • Accurate diagnosis of AH is crucial to avoid unnecessary treatment and complications, highlighting the need for greater awareness and reporting in the medical community to enhance diagnostic accuracy and patient management.
View Article and Find Full Text PDF

Background: Primary hepatic angiosarcoma (PHA) is a rare hepatic malignancy primarily observed in the elderly. It carries a poor prognosis as a result of the characteristics of rapid progression, high aggressiveness, and resistance to traditional chemo- and radiotherapies. Its nonspecific clinical manifestations, along with the lack of laboratory features and various imaging findings, make it hard to recognize in clinic, especially among non-high-risk populations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!